CBD News‎ > ‎


posted Apr 11, 2018, 5:51 AM by Scott Salisbury

Daily update  April 11, 2018
Cannabidiol oil - four health reasons you should be taking CBD oil everyday
CBD OIL, or cannabidiol oil, is used by more than 250,000 people in the UK for a number of health benefits, including for anxiety and relieving pain. ... Cannabidiol (CBD) oil is a neuroactive compound that doesn't give patients a 'high' feeling, but can be used for medicinal purposes, added nutritionist Dr ...
Google PlusFacebookTwitterFlag as irrelevant
Green Gorilla Hires Natural Products Industry Veteran Herb Lewis as Senior Vice President of Sales
Green Gorilla, a leading manufacturer, and brand of cannabidiol (CBD) products, has hired well-known natural products industry sales executive Herb Lewis as its senior vice president of sales. Lewis will be responsible for all sales efforts for the Green Gorilla brand of pure CBD oil products, which is ...
Google PlusFacebookTwitterFlag as irrelevant
The country that pioneered "wellness" is adopting cannabis as a cure
Cannabidiol—the non-psychotropic chemical compound of cannabis that's also known as CBD—is catching on in the now-global wellness community as a treatment for anxiety, joint pain, PTSD, menstrual cramps, insomnia, nausea, seizures, inflammation, and more. In Switzerland's cities, the stuff has ...
Google PlusFacebookTwitterFlag as irrelevant
Dallas CBD Sellers Confused After Texas Announces It Might Confiscate Products
The products contain trace amounts of tetrahydrocannabinol, or THC, less than the federal limit of 0.3 percent. THC is the main compound in marijuana that gets users stoned. Cannabidiol, or CBD, doesn't have that effect, but some say it relieves pain, anxiety, spasms and a host of other ailments.
Google PlusFacebookTwitterFlag as irrelevant
Take Action: FDA Seeking Comment On The International Scheduling Of Cannabis
The United Nations World Health Organization is due to review the current international classification of marijuana, THC, cannabidiol, and other related compounds and preparations this year. In the lead up, the WHO is asking member nations submit feedback, of which no nation is more influential than ...
Google PlusFacebookTwitterFlag as irrelevant
Somehow, the Ridiculous War on Hemp Is Still Going On
Bills had planned to start a business extracting cannabidiol, or CBD oil, the non-psychoactive cannabis chemical used as medicine by many but not recognized as one by authorities. He had rented a plot in California and partnered with a company that claimed to be a university, as well as cannabis ...
Google PlusFacebookTwitterFlag as irrelevant
Marapharm's California Dispensary Will Introduce CBD Products
Marapharm Ventures (CSE:MDM; OTCQX:MRPHF) announced the introduction organic cannabidiol (CBD) health and wellness products for their retail dispensary. As quoted in the press release: Marapharm will launch the sale of three organic skin care products infused with high potency CBD which is ...
Google PlusFacebookTwitterFlag as irrelevant
Applied Biosciences Launches New Line of CBD Products
The new e-store, Remedishop.com, currently offers the Applied Biosciences line of hemp-derived cannabidiol (CBD) isolate infused gummies, topicals and tinctures. Applied Biosciences is continuing to launch its product lines in select specialty and retail stores. The organic CBD gummies come in both ...
Google PlusFacebookTwitterFlag as irrelevant
Marapharm Ventures Inc. To Introduce Organic CBD Health and Wellness Products To Be ...
KELOWNA, BC, April 10, 2018 /CNW/ - Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm" or the "Company") will introduce organic Cannabidiol ("CBD") health and wellness products, to our first retail dispensary on May 1, 2018. Marapharm will launch the sale of three ...
Google PlusFacebookTwitterFlag as irrelevant
Anti-inflammatory properties of cannabidiol, a non-psychotropic cannabinoid, in experimental ...
Anti-inflammatory properties of cannabidiol, a non-psychotropic cannabinoid, in experimental allergic contact dermatitis. Stefania Petrosino, Massimo Vaia, Roberta Verde, Teresa Iuvone and Vincenzo Di Marzo. Journal of Pharmacology and Experimental Therapeutics April 9, 2018, jpet.117.244368; ...
Google PlusFacebookTwitterFlag as irrelevant